Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis

A broadly protective multivalent OspA vaccine based on surface shaping of the C-terminal fragment

(2020) Abhijeet Nayak et al.   INFECTION AND IMMUNITY

OMV Vaccines and the Role of TLR Agonists in Immune Response

(2020) Francesca Mancini et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults

(2019) Federico Martinón-Torres et al.   Human Vaccines & Immunotherapeutics

Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification

(2019) Matthias J.H. Gerritzen et al.   VACCINE

Immunization With Skp Delivered on Outer Membrane Vesicles Protects Mice Against Enterotoxigenic Escherichia coli Challenge

(2018) Michael P. Hays et al.   Frontiers in Cellular and Infection Microbiology

Bacterial outer membrane vesicles, a potential vaccine candidate in interactions with host cells based

(2018) Wei Cai et al.   Diagnostic Pathology

High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis

(2018) Matthias J. H. Gerritzen et al.   Microbial Cell Factories

The Dual Role of Lipids of the Lipoproteins in Trumenba, a Self-Adjuvanting Vaccine Against Meningococcal Meningitis B Disease

(2016) Yin Luo et al.   AAPS Journal

Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions

(2016) Shivender Shandilya et al.   JOURNAL OF MOLECULAR RECOGNITION

Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles

(2016) Merijn L.M. Salverda et al.   VACCINE

Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization

(2015) Kirsten Kuipers et al.   VACCINE

A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

(2014) Nina Wressnigg et al.   Clinical and Vaccine Immunology

Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection

(2014) A Wagemakers et al.   GENE THERAPY

Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis

(2014) Pär Comstedt et al.   PLoS One

Bacterial Outer Membrane Vesicles and Vaccine Applications

(2014) Reinaldo Acevedo et al.   Frontiers in Immunology

Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development

(2013) Bas van de Waterbeemd et al.   PLoS One

Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa

(2013) Rolando Pajon et al.   PLoS One

Bexsero

(2012) Andrew R. Gorringe et al.   Human Vaccines & Immunotherapeutics

A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines

(2011) Oliver Koeberling et al.   Clinical and Vaccine Immunology

Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study

(2011) Anna J Henningsson et al.   Journal of Neuroinflammation

Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles

(2010) Adam Kulp et al.   Annual Review of Microbiology

Immunization withSalmonella entericaSerovar Typhimurium-Derived Outer Membrane Vesicles Delivering the Pneumococcal Protein PspA Confers Protection against Challenge withStreptococcus pneumoniae

(2010) Maneesha Muralinath et al.   INFECTION AND IMMUNITY

Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles

(2010) T. N. Ellis et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Delivery of foreign antigens by engineered outer membrane vesicle vaccines

(2010) D. J. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process

(2010) Bas van de Waterbeemd et al.   VACCINE

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

(2009) Johan Holst et al.   VACCINE

Bactericidal Antibody Responses Elicited by a Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Factor H–Binding Protein and Genetically Attenuated Endotoxin

(2008) Oliver Koeberling et al.   JOURNAL OF INFECTIOUS DISEASES